Perimeter Medical Imaging AI: Developing the Next Generation of Point-of-Care Specimen Imaging Medical Device Investing
Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19 Pharmaceutical Investing
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM) Pharmaceutical Investing
Perimeter Medical Imaging AI Announces Appointment of Aaron Davidson as Director Medical Device Investing
Sona Nanotech Announces Clinical Evaluation Study Results for its COVID-19 Antigen Test Biotech Investing
Mimi’s Rock: Health and Wellness Products Enabling People to Be Their Best Technology Investing News
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
